IRADIMED CORPORATION (IRMD)

Market Cap	756.29M
Revenue (ttm)	75.15M
Net Income (ttm)	19.78M
Shares Out	12.72M
EPS (ttm)	1.55
PE Ratio	38.38
Forward PE	35.62
Dividend	$0.68 (1.14%)
Ex-Dividend Date	May 20, 2025

Volume	102,345
Open	59.40
Previous Close	59.02
Day's Range	59.16 - 59.54
52-Week Range	42.34 - 63.29
Beta	0.93
Analysts	Strong Buy
Price Target	72.00 (+21.05%)
Earnings Date	Jul 31, 2025

About IRMD

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The company offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/contr...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jul 16, 2014
• Employees: 160
• Stock Exchange: NASDAQ
• Ticker Symbol: IRMD
• Website: https://www.iradimed.com

Financial Performance

In 2024, IRADIMED CORPORATION's revenue was $73.24 million, an increase of 11.71% compared to the previous year's $65.56 million. Earnings were $19.23 million, an increase of 11.87%.

Analyst Summary

According to one analyst, the rating for IRMD stock is "Strong Buy" and the 12-month stock price target is $72.0.

Price Target

$72.0

(21.05% upside)

Analyst Consensus: Strong Buy